Page 2 - Vaccine

SII, Bharat Biotech halt production of Covid vaccines as demand slips

High inventory, lack of fresh orders behind the decision; focus on non-Covid vax

US lawsuit may not impact India launch of Gennova's mRNA vaccine

The vaccine is now under review by the regulator, and if approved, it may be ready for launch in the Indian market and will be the first mRNA Covid vaccine to be available here.

Bharat Biotech slows down Covaxin production as it sees decrease in demand

'For the coming period, the company will focus on pending facility maintenance, process and facility optimization activities,' the Hyderabad-based company said

'India may come up with vaccine against tuberculosis by 2024'

Currently, the BCG vaccine is used among children at the time of birth

Finland recommends fourth Covid-19 vaccine dose to people above 80 years

Finland has recommended a fourth Covid-19 vaccine dose for people above 80 years and those living in care homes

Moderna says its low-dose Covid vaccine shots work for kids under 6

The younger the child, the smaller the dose being tested. Moderna said a quarter of the dose it uses for adults worked well for youngsters under age 6

DCGI gives nod to phase-3 clinical trial of Covid vaccine Covovax

The vaccine has not been included in the country's inoculation programme against Covid-19

Four vaccines approved for those below 18 years, govt tells Rajya Sabha

The Central Drugs Standard Control Organization in consultation with Subject Expert Committee has approved four COVID-19 vaccines for restricted use in emergency situation for those aged below 18 years, the Rajya Sabha was informed on Tuesday. The four vaccines which have been approved are Zydus Cadila's ZyCovD (in the age group of 12 years and older), Bharat Biotech's Covaxin (for >2 to <18 years age group), Biological E's Corbevax (for =5 to <18 years age group) and Serum Institute of India's Covovax (for >12 to <18 years age group), Minister of State for Health Bharati Pravin Pawar said in a written reply. The National COVID-19 vaccination programme was expanded to include adolescents aged 15 to 18 years from January 3, 2022. It was further expanded to children of age group 12 -14 years from March 16. The National Covid vaccination programme is guided by National Technical Advisory Group on Immunization (NTAGI) and the National Expert Group on Vaccine ...

Poultry vaccine maker Hester Bio enters pet care, no fresh investment seen

Is now looking to add dermatology, nutrition, grooming, anti-infective and specialty products in this segment

India's Covid vaccination drive epitome of power of Sabka Prayas: Mandaviya

India crossed 750 mn vaccinations milestone on September 7, 2021, and achieved a milestone of 1 bn vaccinations on October 21, 2021

Wockhardt, Serum Institute of India tie up to make vaccines in UK

SII has supplied the AstraZeneca-Oxford vaccine to the UK already, and having a fill-and-finish facility in the UK would help the firm to have closer access to the UK and EU markets.

Two primary doses followed by booster crucial for all: Top virologist

'Immunisation schedule must be completed by all individuals if we have to win this war against Covid,' he said

US scientists develop vaccine that can protect from Nipah virus in 3 days

Nipah is a zoonotic virus (transmitted from animals to humans), which can be spread through contaminated food or directly between humans on exposure to secretions

Over 1.8 bn doses of Covid vaccines administered: Centre tells SC

It said both vaccines -- Covaxin and Covishield -- generate antibodies and adverse events are also found to be minimum

Singapore Airlines to expand VTL network to India, 26 countries: Report

VTL allows quarantine-free travel to Singapore for fully vaccinated travellers

Vaccine for 12-14 age group: Delhi parents relieved as schools reopen

For the first time in two years, schools in the national capital will reopen completely in offline mode from April 1 with the hybrid mode of operation coming to an end

Over 1.8 bn Covid vaccine doses administered in India so far: Govt

Over 2.12 crore precaution doses have been administered to the identified categories of beneficiaries so far, the ministry said

Biological E seeks EUA for Corbevax for children in 5-12 age group

In February, the Biological E had received the EUA for Corbevax from India's drug regulator Drugs Controller General of India (DCGI) for the 12 to 18 age group

Moderna plots vaccines for 15 pathogens with pandemic potential

The company is rowing back, announcing an agreement on Monday to open a vaccine plant in Kenya that will make as many as 500 million doses annually

WHO says it 'strongly supports' Covid booster, reversing previous call

WHO said it is continuing to monitor the global spread of omicron, including a stealth version known as BA.2, which has been documented to have re-infected some people after an initial case of omicron